Effectiveness of chemotherapy in melanotic neurectodermal tumor of infancy

Pediatr Hematol Oncol. 2005 Apr-May;22(3):199-206. doi: 10.1080/08880010590921450.

Abstract

MNTI is an uncommon tumor mainly of infants. Surgery is the primary modality of treatment. Chemotherapy has been tried for recurrent/residual tumors. The chemotherapeutic response of 3 infants treated at a center is discussed here. All 3 infants showed good response to chemotherapy. In 2 of them complete residual tumor resection became possible; 2 of them are alive and tumor regression continues. One child had local recurrence later and was lost for follow-up.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Humans
  • Infant
  • Male
  • Neoplasm Recurrence, Local
  • Neoplasm, Residual / drug therapy*
  • Neoplasm, Residual / surgery
  • Neuroectodermal Tumor, Melanotic / drug therapy*
  • Neuroectodermal Tumor, Melanotic / surgery
  • Orbital Neoplasms / drug therapy*
  • Orbital Neoplasms / surgery
  • Pigmentation
  • Skull Neoplasms / drug therapy*
  • Skull Neoplasms / surgery
  • Temporal Bone / pathology*
  • Treatment Outcome